C. Lippert

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study.

P. Albers, M. Moore, I. Bodrogi, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Histology-based prediction of lymph node metastases in early gastric cancer as decision guidance for endoscopic resection

R. Grobholz, S. Post, T. Gaiser, 2016, Oncotarget.

Leiomyosarkom des Samenstranges mit paraneoplastischer β-hCG Produktion

V. Grouls, C. Lippert, C. Seidl, 1998, Der Pathologe.

Clinical Outcome and Quality of Life After a Multimodal Therapy Approach to Ear Keloids.

K. Hörmann, C. Weiss, Ute Walliczek, 2015, JAMA facial plastic surgery.

Platelet and monocyte activity markers and mediators of inflammation in Takotsubo cardiomyopathy

M. Borggrefe, S. Lang, D. Haghi, 2012, Heart and Vessels.

Predicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system.

A. Seely, G. Darling, D. Mulder, 2013, Journal of the American College of Surgeons.

Gemcitabin/Cisplatin vs. MVAC

P. Albers, M. Stöckle, L. Weissbach, 2003, Der Urologe, Ausgabe A.

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study.

I. Bodrogi, P. Conte, L. Dogliotti, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study.

I. Bodrogi, P. Conte, H. von der Maase, 2023, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.